Business Description
Phio Pharmaceuticals Corp. is a US-based company focused on developing new cancer treatments that work by modifying how immune cells behave. Its two lead programs target specific proteins ? PD-1 and BRD4 ? that play a role in how cancer grows and evades the body's defenses. Founded in 2003 and headquartered in King of Prussia, Pennsylvania, the company has been operating under its current name since 2018.
